Effects of volatile anesthetic choice on hospital length-of-stay: A retrospective study and a prospective trial

Anesthesiology

Volumn 119, Issue 1, 2013, Pages 61-70

  Kopyeva, Tatyana ^a   Sessler, Daniel I ^a   Weiss, Stephanie ^b,c   Dalton, Jarrod E ^a   Mascha, Edward J ^a   Lee, Jae H ^a   Kiran, Ravi P ^a   Udeh, Belinda ^a   Kurz, Andrea ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; FENTANYL; HYDROMORPHONE; ISOFLURANE; MIDAZOLAM; MORPHINE; NITROUS OXIDE; PROPOFOL; SEVOFLURANE;

ADULT; AGED; ANESTHESIST; ARTICLE; COLORECTAL SURGERY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GASTROINTESTINAL SURGERY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOTHESIS; INHALATION ANESTHESIA; INTERVENTION STUDY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY;

ADULT; AGED; ANALGESICS, OPIOID; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; ISOFLURANE; LENGTH OF STAY; LOGISTIC MODELS; MALE; METHYL ETHERS; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84883234042     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318295262a     Document Type: Article

References (19)

1. Stachnik J: Inhaled anesthetic agents. Am J Health Syst Pharm 2006; 63:623-34
2. Chernin EL: Pharmacoeconomics of inhaled anesthetic agents: Considerations for the pharmacist. Am J Health Syst Pharm 2004; 61(suppl 4):S18-22
3. Smith I: Cost considerations in the use of anaesthetic drugs. Pharmacoeconomics 2001; 19(5 Pt 1):469-81
4. Odin I, Feiss P: Low flow and economics of inhalational anaesthesia. Best Pract Res Clin Anaesthesiol 2005; 19:399-413
5. Sakai EM, Connolly LA, Klauck JA: Inhalation anesthesiology and volatile liquid anesthetics: Focus on isoflurane, desflurane, and sevoflurane. Pharmacotherapy 2005; 25:1773-88
6. Drug Topics Red Book, Montvale, NJ, Thomson Healthcare, 2010
7. Weinberg L, Story D, Nam J, McNicol L: Pharmacoeconomics of volatile inhalational anaesthetic agents: An 11-year retrospective analysis. Anaesth Intensive Care 2010; 38:849-54
8. Nickalls RW, Mapleson WW: Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth 2003; 91:170-4
9. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD: Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesth esiology 1995; 82:1379-88
10. Dexter F: Impact on operating room efficiency of reducing turnover times and anesthesia-controlled times. Ann Surg 2007; 245:336-7
11. Zhang Y, Eger EI II , Dutton RC, Sonner JM: Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg 2000; 91:462-6
12. Flood P, Sonner JM, Gong D, Coates KM: Isoflurane hyperalgesia is modulated by nicotinic inhibition. Anesth esiology 2002; 97:192-8
13. Sessler DI, Sigl JC, Manberg PJ, Kelley SD, Schubert A, Chamoun NG: Broadly applicable risk stratification system for predicting duration of hospitalization and mortality. Anesth esiology 2010; 113:1026-37
14. Saklad M: Grading of patients for surgical procedures. Anesth esiology 1941; 2:281-4
15. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ: Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007; 45(10 suppl 2):S103-7
16. Ledolter J, Dexter F, Epstein RH: Analysis of variance of communication latencies in anesthesia: Comparing means of multiple log-normal distributions. Anesth Analg 2011; 113:888-96
17. I oannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J: Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286:821-30
18. Ioannidis JP: Contradicted and initially stronger effects in highly cited clinical research. JAMA 2005; 294:218-28
19. Dexter F, Epstein RH: Typical savings from each minute reduction in tardy first case of the day starts. Anesth Analg 2009; 108:1262-7